A Study to Assess How the Drug Moves Through the Body, Adverse Events, and Tolerability of Oral ABBV-722 Capsules of Single and Multiple Ascending Doses in Adult Participants and Single Doses in Adult Asian Participants

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This is a Phase 1, first-in-human study to investigate safety, tolerability, and pharmacokinetics of ABBV-722 after oral dosing in healthy adult participants.
Epistemonikos ID: c85f065b70f6516ddff9e884a4744768698f10da
First added on: Dec 01, 2024